We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

111 hedge funds and large institutions have $158M invested in VanEck Biotech ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

463% more call options, than puts

Call options by funds: $2.72M | Put options by funds: $484K

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

16% more capital invested

Capital invested by funds: $136M → $158M (+$21.7M)

6% more funds holding

Funds holding: 105 → 111 (+6)

0.59% less ownership

Funds ownership: 28.06% → 27.47% (-0.59%)

4% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 27

Holders
111
Holders Change
+6
Holders Change %
+5.71%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
26
Reduced
27
Closed
7
Calls
$2.72M
Puts
$484K
Net Calls
+$2.24M
Net Calls Change
+$1.23M

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.79M
2
FTUS
Flow Traders U.S.
New York
+$1.54M
3
WANY
Wealthspire Advisors (New York)
New York
+$1.37M
4
PP
Prudential plc
United Kingdom
+$931K
5
Millennium Management
Millennium Management
New York
+$589K

Top Sellers

1
FP
Financial Perspectives
Minnesota
-$2.86M
2
KAS
Kestra Advisory Services
Texas
-$2.1M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.05M
4
BRC
BHF RG Capital
Arizona
-$1.96M
5
Goldman Sachs
Goldman Sachs
New York
-$527K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$23.5M -$527K -2,830 -2%
Morgan Stanley
2
Morgan Stanley
New York
$12.7M -$209K -1,125 -2%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$10.8M +$315K +1,691 +3%
UBS Group
4
UBS Group
Switzerland
$8.56M +$334K +1,795 +4%
MCM
5
Murphy Capital Management
New Jersey
$6.81M -$36.9K -198 -0.6%
Bank of America
6
Bank of America
North Carolina
$6.42M -$297K -1,596 -5%
KAS
7
Kestra Advisory Services
Texas
$6.22M -$2.1M -11,253 -27%
MJRIC
8
Mogy Joel R Investment Counsel
California
$5.93M +$294K +1,580 +6%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$4.92M +$1.79M +9,633 +65%
LPL Financial
10
LPL Financial
California
$4.48M +$236K +1,266 +6%
Stifel Financial
11
Stifel Financial
Missouri
$4.2M +$76.7K +412 +2%
Commonwealth Equity Services
12
Commonwealth Equity Services
Massachusetts
$3.4M +$135K +727 +5%
WANY
13
Wealthspire Advisors (New York)
New York
$3.22M +$1.37M +7,367 +86%
FFN
14
Focus Financial Network
Minnesota
$3.12M -$66.5K -357 -2%
BRM
15
Boston Research & Management
Massachusetts
$2.68M -$70.7K -380 -3%
RJA
16
Raymond James & Associates
Florida
$2.39M +$378K +2,031 +21%
Rockefeller Capital Management
17
Rockefeller Capital Management
New York
$2.3M – – –
HighTower Advisors
18
HighTower Advisors
Illinois
$2.17M +$39.8K +214 +2%
CCA
19
Conservest Capital Advisors
Pennsylvania
$2.04M – – –
LFASL
20
Lugano Financial Advisors SA (LFA)
Switzerland
$1.91M +$39.8K +214 +2%
Envestnet Asset Management
21
Envestnet Asset Management
Illinois
$1.89M +$242K +1,300 +16%
GT
22
Glenview Trust
Kentucky
$1.88M – – –
Janney Montgomery Scott
23
Janney Montgomery Scott
Pennsylvania
$1.77M – – –
FTUS
24
Flow Traders U.S.
New York
$1.67M +$1.54M +8,268 New
SFPG
25
Stonebridge Financial Planning Group
Florida
$1.58M +$168K +905 +13%
1
2 3 4 5

BBH Hedge Fund Activity: Q2 2021 in Review

111 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2021, worth a combined $158M — up 16% from $136M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 7 closed out — a net gain of 6 holders — while 26 added to existing stakes and 27 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $1.79M. The largest seller was Financial Perspectives, cutting an estimated $2.86M.

  • 111 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2021, up from 105 in Q1 2021.
  • Funds reported $158M of VanEck Biotech ETF stock for Q2 2021, up 16% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q2 2021 and 7 closed out, a net change of +6 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2021 was Susquehanna International Group, an estimated $1.79M added.
  • The largest VanEck Biotech ETF seller in Q2 2021 was Financial Perspectives, an estimated $2.86M sold.

Based on aggregated 13F filings for Q2 2021.